Pharmacy Reimbursement • Professional Dispensing Fee • PBM Regulation • Arkansas

Arkansas Reports $10.50 Generic Dispensing Fee Across About 1,052 Plans

Arkansas’s Insurance Department reports that the $10.50 additional cost to dispense generic medications has been implemented across approximately 1,052 health benefit plans, compared with approximately 100 in October. Its report dated November 20 also identifies pending plan appeals. These figures concern Arkansas’s reimbursement framework and do not establish a nationwide payment requirement. Chad’s analysis: the expansion provides a practical example of separating drug acquisition reimbursement from payment for dispensing services, while actual entitlement and payment still require plan-specific verification.

By Toby C. “Chad” Frost • November 20, 2026
1 min read

Implementation expands

The Arkansas Insurance Department’s report dated November 20 puts implementation of the $10.50 additional generic dispensing cost at approximately 1,052 health benefit plans. The October 16 report put that figure at approximately 100. Both identify final determinations sent to 28 PBMs. The November report says plan appeals are being processed.12

The report’s first public posting time has not been confirmed. The development is the materially larger implementation count in the dated monthly report. It is not a new nationwide dispensing-fee requirement.123

Scope follows the applicable determination

Rule 128 permits the Commissioner to review pharmacy compensation and require an additional dispensing cost where the program does not provide fair and reasonable reimbursement sufficient for an adequate pharmacy network. The rule contains federal and state-law exemptions. A pharmacy should not infer from the aggregate count that every plan or prescription qualifies.3

Operational analysis

Chad’s analysis: drug acquisition reimbursement and payment for the professional work of dispensing should be evaluated separately. For an affected Arkansas business, identify the applicable plan determination, confirm its terms and reconcile the amounts actually paid. The larger implementation count shows broader use of this state framework; it does not by itself establish that individual pharmacies received every payment owed or that the fee covers their operating costs.123

Source notes

  1. Ark. Ins. Dep’t, Report from AID Concerning Rule 128: Fair and Reasonable Pharmacy Reimbursements 1 (Nov. 20, 2026).
  2. Ark. Ins. Dep’t, Report from AID Concerning Rule 128: Fair and Reasonable Pharmacy Reimbursements 1 (Oct. 16, 2026).
  3. Ark. Ins. Dep’t, Rule 128: Fair and Reasonable Pharmacy Reimbursements §§ III–IV, at 2–4 (codified at 23 Code Ark. Rules pt. 148).